| Patient | Gender | Age | Diagnosis | Duration (years) | ESR | RF (titre) | Histology score | Medication |
| 1 | M | 52 | Normal (meniscal tear) | 1.2 | ND | ND | 0 | None |
| 2 | F | 53 | Normal (articular cartilage degeneration) | 0.25 | ND | ND | 1 | None |
| 3 | M | 57 | Normal (articular cartilage degeneration) | 1 | ND | ND | 0 | None |
| 4 | F | 57 | Normal (meniscal tear) | 1.5 | ND | ND | 0 | None |
| 5 | M | 58 | Normal (meniscal tear and cartilage degeneration) | 0.5 | ND | ND | 0 | None |
| 6 | F | 41 | Normal (articular cartilage degeneration) | 0.5 | ND | ND | 0 | None |
| 7 | M | 38 | Normal (articular cartilage damage) | 1 | ND | ND | 0 | None |
| 8 | F | 55 | Normal (meniscal and articular cartilage damage) | 2 | ND | Negative | 0 | None |
| 9 | F | 29 | Normal (articular cartilage degeneration) | 11 | <10 | Negative | 0 | None |
| 10 | M | 28 | Normal (meniscal tear) | 1 | ND | ND | 0 | None |
| 11 | M | 44 | Normal (meniscal tear) | 15 | ND | ND | 0 | NSAID |
| 12 | M | 55 | Normal (articular cartilage damage) | >1 | ND | ND | 0 | None |
| 1 | ND | ND | ERA | 1.5 | 14 | Positive (640) | 3 | NSAID |
| 2 | ND | ND | ERA | 0.25 | 23 | Positive (80) | 1 | NSAID |
| 3 | ND | ND | ERA | 0.6 | ND | ND | 1 | ND |
| 4 | ND | ND | ERA | 0.25 | 51 | Positive (640) | 2 | NSAID |
| 5 | ND | ND | ERA | 0.5 | 44 | Positive (640) | 2 | None |
| 6 | ND | ND | ERA | 0.3 | 34 | Positive (170) | 1 | None |
| 7 | ND | ND | ERA | 1 | 48 | Positive (160) | 2 | None |
| 8 | ND | ND | ERA | 0.1 | 12 | Positive (640) | 3 | NSAID |
| 1 | F | 48 | RA | 18 | 24 | Positive (400) | 3 | MTX, NSAID |
| 2 | F | 47 | RA | 15 | 18 | Negative | 1 | St, NSAID, analgesic |
| 3 | F | 62 | RA | 26 | 64 | Positive (>1280) | 2 | Sulphasalazine, NSAID |
| 4 | F | 45 | RA | 20 | 71 | Positive (640) | 3 | Sulphasalazine, azathioprine, NSAID |
| 5 | M | 73 | RA | 15 | 59 | Positive(1280) | 2 | d-Penicillamine, NSAID, analgesic |
| 6 | F | 43 | RA | 5 | 23 | Positive (640) | 2 | MTX |
| 7 | F | 52 | RA | 20 | 30 | Positive (1280) | 3 | MTX, Hydroxychloroquine, NSAID, st, gold |
| 8 | F | 67 | RA | 7 | 105 | Positive (160) | 3 | Steroid, NSAID |
| 9 | F | 63 | RA | 8 | 100 | Positive (320) | 3 | MTX, st, analgesic |
| 10 | F | 62 | RA | 38 | 100 | Positive (640) | 3 | MTX, st |
| 11 | F | 55 | RA | 21 | 68 | Positive (1280) | 2 | NSAID |
| 13 | F | 68 | RA | 28 | 70 | Positive (800) | 2 | Analgesic |
| 1 | M | 42 | OA | 2 | ND | Negative | 1 | None |
| 2 | F | 61 | OA | >4 | ND | ND | 2 | Analgesic |
| 3 | F | 72 | OA | >5 | ND | ND | 1 | NSAID, analgesic |
| 4 | F | 33 | OA | 20 | ND | Negative | 1 | NSAID |
| 5 | M | 78 | OA | 15 | ND | ND | 1 | NSAID |
| 6 | F | 83 | OA | 13 | ND | ND | 2 | NSAID |
| 1 | M | 22 | PsA | 8 | 11 | Negative | 1 | Aulin |
| 2 | F | 40 | PsA | <1 | 28 | Negative | 2 | NSAID, st, tar pomeda, reductil |
| 3 | F | 60 | PsA | 13 | 4 | Negative | 2 | Betnovate, Lipitor |
| 4 | F | 50 | PsA | <1 | 5 | Negative | 0 | DMARD |
| 5 | M | 35 | PsA | 2 | 11 | Negative | 2 | NSAID, Losec, analgesic |
| 6 | F | 55 | PsA | 28 | 10 | Negative | 3 | St, MTX |
| 7 | F | 27 | PsA | 20 | 24 | Negative | 3 | NSAID, st |
DMARD, disease-modifying antirheumatic drug; ERA, early rheumatoid arthritis; MTX, methotrexate; ND, not determined; NSAID, non-steroidal anti-inflammatory drug; OA, osteoarthritis; PsA, psoriatic arthritis; RA longstanding rheumatoid arthritis; RF, rheumatoid factor; St, steroid.